Howell, Charles D.

Publishing since 1988 (Dinosaur)

Has published 33 publications in 22 years

Number of publications published per year by Howell, Charles D.. (Source : PubMed)

Distribution of publications types for Howell, Charles D.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Howell CD. Racial disparities in liver transplantation for hepatitis B: to be or not to be.  Liver Transpl.  2009;15;9  
•  Hoofnagle JH, Wahed AS, Brown RS, Howell CD, Belle SH. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.  J. Infect. Dis.  2009;199;8  
•  Huang C, Chen H, Cassidy W, Howell CD. Peripheral blood gene expression profile associated with sustained virologic response after peginterferon plus ribavirin therapy for chronic hepatitis-C genotype 1.  J Natl Med Assoc  2008;100;12  
•  Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.  Clin. Gastroenterol. Hepatol.  2008;6;5  
•  Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.  Proc. Natl. Acad. Sci. U.S.A.  2007;104;3  
•  Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.  Gastroenterology  2006;131;2  
•  Howell CD, Jeffers LS, Cassidy W, Reddy KR, Hu S, Lee JS. Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response.  J. Viral Hepat.  2006;13;6  
•  Yu L, Sloane DA, Guo C, Howell CD. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000.  Clin. Gastroenterol. Hepatol.  2006;4;3  
•  Luo S, Cassidy W, Jeffers L, Reddy KR, Bruno C, Howell CD. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.  Clin. Gastroenterol. Hepatol.  2005;3;5  
•  Jeffers LJ, Cassidy W, Howell CD, Hu S, Reddy KR. Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.  Hepatology  2004;39;6  

[ See timeline ] [ See all publications ]